General objective:In view of the recent advancements of the MOOD’s study cases, the coordination team has planned a hybrid meeting among MOOD’s case facilitators, task leaders, and researchers involved in each case study to identify and discuss selected tools to be developed and presented to end-users by the end of the project (generic tools and disease-specific ones); The meeting will also be ane opportunity to plan a coordinated timetable (from data to tools and interactions among researchers and with end-users).
General information:
The meeting will take place over two days, starting from December 8th (1-6 PM), when MOOD participants will present essential aspects related to the development of the tools, and discuss implementation advancements for Antimicrobial Resistance  (AMR), Avian Influenza (Avian Flu), Tick-borne Encephalitis (TBE) , and West Nile (WN).
The following day, 10th December (8.30 AM to 12 PM), presentations will continue with COVID-19 (disease X), and other diseases covered by the MOOD project (Chi-De-Zi Tul Lepto & other tools).
The meeting will be live-streamed for MOOD’s partners participating virtually.